Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1987 1
1999 1
2001 1
2005 3
2006 2
2007 2
2008 2
2009 11
2010 12
2011 12
2012 8
2013 20
2014 9
2015 9
2016 11
2017 9
2018 6
2019 17
2020 26
2021 27
2022 27
2023 20
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

218 results

Results by year

Filters applied: . Clear all
Page 1
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
BACKGROUND: Bapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clinical development for the treatment of Alzheimer's disease. METHODS: We conducted two double-blind, randomized, placebo-controlled, phase 3 trials involving patients with mild-to-moderate …
BACKGROUND: Bapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clinical development for the treatment of Alzheimer's …
Is cyclooxygenase-1 involved in neuroinflammation?
Ghazanfari N, van Waarde A, Dierckx RAJO, Doorduin J, de Vries EFJ. Ghazanfari N, et al. J Neurosci Res. 2021 Nov;99(11):2976-2998. doi: 10.1002/jnr.24934. Epub 2021 Aug 4. J Neurosci Res. 2021. PMID: 34346520 Free PMC article. Review.
The same imaging method, however, could not detect any upregulation of COX-1 in patients with Alzheimer's disease. CONCLUSION: Taken together, studies in cultured cells and living rodents suggest that COX-1 is involved in neuroinflammation. ...
The same imaging method, however, could not detect any upregulation of COX-1 in patients with Alzheimer's disease. CONCLUSION: Taken …
Updates on Tinea Incognita: Literature review.
Ghaderi A, Tamimi P, Firooz A, Fattahi M, Ghazanfari M, Fattahi M. Ghaderi A, et al. Curr Med Mycol. 2023 Jun;9(2):52-63. doi: 10.22034/cmm.2023.345069.1425. Curr Med Mycol. 2023. PMID: 38375520 Free PMC article. Review.
Medical application of biomimetic 4D printing.
Shakibania S, Ghazanfari L, Raeeszadeh-Sarmazdeh M, Khakbiz M. Shakibania S, et al. Drug Dev Ind Pharm. 2021 Apr;47(4):521-534. doi: 10.1080/03639045.2020.1862179. Epub 2021 Apr 15. Drug Dev Ind Pharm. 2021. PMID: 33307855 Review.
Additive manufacturing has attracted a lot of attention in fabrication of bio medical devices and structures in recent years. 4D printing, a new class of 3D printing where time is considered as a 4th dimension, allows us to build biological structures such as scaffolds, implants, …
Additive manufacturing has attracted a lot of attention in fabrication of bio medical devices and structures in recent years. 4D printing, a …
Strategies to Identify Mesenchymal Stromal Cells in Minimally Manipulated Human Bone Marrow Aspirate Concentrate Lack Consensus.
Ruoss S, Walker JT, Nasamran CA, Fisch KM, Paez CJ, Parekh JN, Ball ST, Chen JL, Ahmed SS, Ward SR. Ruoss S, et al. Am J Sports Med. 2021 Apr;49(5):1313-1322. doi: 10.1177/0363546521993788. Epub 2021 Mar 1. Am J Sports Med. 2021. PMID: 33646886 Free PMC article.
Strategies included (1) the guidelines by the International Society for Cellular Therapy (ISCT), (2) CD271 expression, (3) the Ghazanfari et al transcriptional profile, (4) the Jia et al transcriptional profile, and (5) the Silva et al transcriptional profile. ...Of 12,850 …
Strategies included (1) the guidelines by the International Society for Cellular Therapy (ISCT), (2) CD271 expression, (3) the Ghazanfari …
Developing a hospital accreditation model: a Delphi study.
Mosadeghrad AM, Ghazanfari F. Mosadeghrad AM, et al. BMC Health Serv Res. 2021 Aug 27;21(1):879. doi: 10.1186/s12913-021-06904-4. BMC Health Serv Res. 2021. PMID: 34445975 Free PMC article. Review.
BACKGROUND: Hospital accreditation (HA) is an external evaluation of a hospital's structures, processes and results by an independent professional accreditation body using pre-established optimum standards. ...These constructs were further broken into 43 sub-constructs. Th …
BACKGROUND: Hospital accreditation (HA) is an external evaluation of a hospital's structures, processes and results by an independent …
Laser Aided Ceramic Restoration Removal: A Comprehensive Review.
Ghazanfari R, Azimi N, Nokhbatolfoghahaei H, Alikhasi M. Ghazanfari R, et al. J Lasers Med Sci. 2019 Spring;10(2):86-91. doi: 10.15171/jlms.2019.14. Epub 2019 Feb 25. J Lasers Med Sci. 2019. PMID: 31360375 Free PMC article. Review.
The time of debonding took an average of 190 seconds in Rechmann's study and 106 seconds in Morford's study. One of the main issues while using the laser is thermal irritation of the pulp. ...
The time of debonding took an average of 190 seconds in Rechmann's study and 106 seconds in Morford's study. One of the main i …
Is COVID-19 severity unrelated to antinuclear antibodies?
Vahabi M, Mirsharif ES, Ghazanfari T. Vahabi M, et al. Transpl Immunol. 2023 Jun;78:101791. doi: 10.1016/j.trim.2023.101791. Epub 2023 Jan 20. Transpl Immunol. 2023. PMID: 36682573 Free PMC article.
218 results